Rob Shuster
Analyst · D.A. Davidson. Please go ahead
Well, I’d say a couple. One is the -- is the performance-based comp. I mean it -- as we moved into the last half of the year that was -- I probably underestimated on some of the various components where we were going to land for the year. So you have, what I would call, sort of, a catch-up component, as you move through the year. To give you some reference point, a year ago, we were tracking at about 100% of what we would call our target incentive comp levels. This year, we’re tracking at about 145%. So that’s certainly part of it. Now we don’t do is, as well as anticipated that moves in the other direction. And to just give you some sense of the waiting, I mean, earnings per share is about 32%. There’s a couple of asset quality metrics, NPAs and net charge-offs, which are both 8% efficiency ratio, 16% loan growth, 8% deposit growth, 8% -- if you add that up that’s 80. And then, individual targets for that particular person as the other 20. So that would be a part of it. Another part of it was the healthcare costs, but we expect to recover a chunk of that. And then, probably, the last thing would just be maybe a little bit of an increase in just overall cost on the comp side, we’re just seeing some lift from the competitive standpoint in a wage rates. And then the final piece, I would say, is we have a certain level of compensation that we differ related to direct loan origination costs, and as are in particular mortgage volumes, decline a bit, that deferral of direct loan origination costs, which the primary component is compensation that deferral goes down a bit. So that sort of boosts up. I mean, you could, kind of, think about it that our level of the percent of people doing, processing, closing, et cetera, that there’s a little bit less -- there’s a little more downtime as volumes go lower. So we’re deferring a little bit less in direct origination costs. So that collection of items would be the kind of group that would influence it the most.